Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Screening della libreria di shRNA in pool per…
JoVE Journal
Cancer Research
Author Produced

A subscription to JoVE is required to view this content.

JoVE Journal Cancer Research
Screening della libreria di shRNA in pool per identificare i fattori che modulano un fenotipo di resistenza ai farmaci
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)
Journal (Cancer Research)
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Journal (Cancer Research)
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
 
Click here for the English version

Screening della libreria di shRNA in pool per identificare i fattori che modulano un fenotipo di resistenza ai farmaci

Article DOI: 10.3791/63383-v • 14:51 min • June 17th, 2022
June 17th, 2022 •
1,2, 1,2, 2,3, 2,3, 1,2,3, 1,2,3
1Department of Clinical Haematology, Christian Medical College, 2Department of Biotechnology, Thiruvalluvar University, 3Centre for Stem Cell Research, Christian Medical College

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Lo screening dell'interferenza dell'RNA ad alto rendimento (RNAi) utilizzando un pool di shRNA lentivirali può essere uno strumento per rilevare bersagli letali sintetici terapeuticamente rilevanti nelle neoplasie maligne. Forniamo un approccio di screening dello shRNA aggregato per studiare gli effettori epigenetici nella leucemia mieloide acuta (LMA).

Tags

Cancer Research Screening ad alto rendimento screening RNAi shRNA fattore epigenetico citarabina resistenza AraC
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter